Jonathan Guest is Chief Executive Officer and Vice President for Legal Affairs at the Hereditary Disease Foundation, based out of New York Presbyterian Hospital in Manhattan.
He has advised early-stage companies on matters of entity selection, capital structure, "angel" and venture capital finance, secured loans, executive compensation, intellectual property protection, and technology licensing. Additionally, he has advised companies engaged in telecommunications, e-commerce and software, and his clients include publicly-traded U.S., Canadian, U.K. and Australian companies involved in pharmaceuticals and drug development, oil and gas, natural resource exploration and production, and commercial real estate.
Jonathan has been a partner at several AmLaw 100 firms, and his extensive experience encompasses federal and state securities law matters encountered by foreign companies seeking to raise capital and have their securities traded in the United States. His focus has included debt and equity finance (public and private offerings, including shelf regulations, registered direct offerings, PIPEs and rights offerings), corporate governance (Sarbanes-Oxley compliance) and domestic and cross-border mergers and acquisitions.
Jonathan was selected as a Massachusetts Super Lawyers, 2004 – 2011, and was listed in Chambers & Partners USA Guide
, an annual listing of the leading business lawyers and law firms in the world, 2008 and 2009 editions.